Hyaluronan-modified nanoparticles for tumor-targeting

Expert Opinion on Drug Delivery
Yu Sakurai, Hideyoshi Harashima

Abstract

Introduction: Hyaluronan (HA), a natural polysaccharide, is produced in large amounts by the human body. Since its receptor CD44 is highly expressed in many types of cancers, HA is a promising ligand for cancer-targeting nanoparticles (NPs). Since the enhanced permeability and retention (EPR) effect-based strategy faces difficulties in terms of efficiency in clinical studies, studies focusing on HA-modified NPs that can actively target cancer cells should be prominent for further progress in NP-based cancer treatment. Areas covered: Various materials combined with HA composed of lipid nanoparticles and polymers as well as iron, gold and other metals have been examined. In addition, their cargos have been quite diverse and include small molecule drugs, imaging agents, proteins and nucleic acids. We summarize recent studies on varieties of NPs and describe the properties of HA as a ligand of CD44. Expert opinion: In spite of a number of studies on HA-based NPs, there is few examples of HA-based NPs in clinical. In order to make a progress in clinical study, an evaluation methodology of HA-NPs should be unified and normalized.

References

Jun 1, 1977·Acta Ophthalmologica·S Osterlin
Feb 1, 1992·The Journal of Cell Biology·M CultyC B Underhill
Jun 1, 1992·The Journal of Cell Biology·C HardwickE A Turley
May 9, 1986·Biochimica Et Biophysica Acta·L D MayerP R Cullis
Dec 1, 1980·Analytical Biochemistry·U B Laurent, A Tengblad
Feb 1, 1995·European Journal of Immunology·A PerschlR Hyman
Jan 1, 1994·Progress in Histochemistry and Cytochemistry·R TammiM Tammi
Jan 1, 1997·Advances in Cancer Research·D NaorD Ish-Shalom
Sep 1, 1997·Molecular and Cellular Biology·D D MosserB Massie
Feb 26, 1999·The Journal of Cell Biology·S BanerjiD G Jackson
Jul 30, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·W T GodbeyA G Mikos
Nov 24, 1999·The Journal of Biological Chemistry·B ZhouP H Weigel
Jun 8, 2001·The Journal of Biological Chemistry·M RuponenA Urtti
Jul 14, 2001·The Journal of Biological Chemistry·R TammiM Tammi
Feb 6, 2002·Matrix Biology : Journal of the International Society for Matrix Biology·Warren KnudsonCheryl B Knudson
Jan 7, 2003·IUBMB Life·Naoki Itano, Koji Kimata
Feb 4, 2006·Blood·Eric VachonGregory P Downey
Jul 11, 2006·European Journal of Cell Biology·Robert SternKazuki N Sugahara
Feb 13, 2007·Nature Structural & Molecular Biology·Suneale BanerjiDavid G Jackson
May 18, 2007·Annual Review of Cell and Developmental Biology·Dianhua JiangPaul W Noble
May 24, 2008·The Journal of Surgical Research·Shuang CaiM Laird Forrest
Jul 26, 2008·Nature Nanotechnology·Lizeng GaoXiyun Yan
Jan 27, 2009·Experimental and Molecular Pathology·Alaa AfifyLaura Nguyen
Mar 3, 2011·The FEBS Journal·Raija H TammiMarkku I Tammi
Aug 13, 2011·Journal of the American Chemical Society·Layal L RouhanaJoseph B Schlenoff
Aug 19, 2011·Accounts of Chemical Research·Ji Eun LeeTaeghwan Hyeon
Jul 12, 2012·Angewandte Chemie·Muthusamy JayaramanMichael J Hope
Oct 4, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rikke V BenjaminsenThomas L Andresen
Nov 7, 2012·The Journal of Biological Chemistry·Mark E LauerVincent C Hascall
Mar 9, 2013·Journal of Materials Science. Materials in Medicine·F RossoR V Iaffaioli
Oct 29, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shanthi GaneshMansoor M Amiji
Nov 28, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ju-Hwan ParkDae-Duk Kim
Jul 6, 2014·Colloids and Surfaces. B, Biointerfaces·Ju-Hwan ParkDae-Duk Kim
Jul 10, 2014·Journal of Cancer Research and Clinical Oncology·Remon BazakTamer Refaat
Jul 16, 2014·Cellular Signalling·Lubomir ProchazkaJaroslav Turanek

❮ Previous
Next ❯

Citations

May 11, 2021·Biomedical Materials·Qingmei SunJianzhong Du
Sep 24, 2020·Current Topics in Medicinal Chemistry·Menghan GaoWeiqi Zhang
Aug 29, 2021·Pharmaceutics·Ana Luiza C de S L OliveiraRaimundo Fernandes de Araújo Junior

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.